ES8605510A1 - Procedimiento para preparar derivados de bencilftalazinona sustituidos - Google Patents

Procedimiento para preparar derivados de bencilftalazinona sustituidos

Info

Publication number
ES8605510A1
ES8605510A1 ES546971A ES546971A ES8605510A1 ES 8605510 A1 ES8605510 A1 ES 8605510A1 ES 546971 A ES546971 A ES 546971A ES 546971 A ES546971 A ES 546971A ES 8605510 A1 ES8605510 A1 ES 8605510A1
Authority
ES
Spain
Prior art keywords
substituted benzyl
phthalazinone derivatives
group
phthalazinone
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES546971A
Other languages
English (en)
Other versions
ES546971A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asta Medica GmbH
Original Assignee
Asta Werke AG Chemische Fabrik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Werke AG Chemische Fabrik filed Critical Asta Werke AG Chemische Fabrik
Publication of ES546971A0 publication Critical patent/ES546971A0/es
Publication of ES8605510A1 publication Critical patent/ES8605510A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR DERIVADOS DE BENCILFTALAZINONA SUSTITUIDOS. COMPRENDE: A) CONDENSAR A UN COMPUESTO DE FORMULA (II) CON UNA HIDRAZINA DE FORMULA (H2N-CH-Z) (ZFH), EN BENCENO, CLOROFORMO, TETRAMETILUREA, ETANOL O DIOXANO, Y ENTRE 40J Y 200JC; Y B) HACER REACCIONAR AL PRODUCTO DE A) CON UN COMPUESTO DE FORMULA (Y-Q), EN PRESENCIA DE HIDROXIDOS ALCALINOS, EN DIMETILFORMAMIDA O TOLUENO Y ENTRE 80J Y 200JC, PARA OBTENER UN COMPUESTO DE FORMULA (I) Y SUS SALES FISIOLOGICAMENTE INOCUAS. SIENDO: R, BENCILO, FENILETILO, METOXIETILO O ALILO; Z, H; Q, UN RADICAL DE FORMULA (III); E Y, HAL. SE UTILIZAN COMO ANTIALERGICOS Y PROFILACTICOS CONTRA EL ASMA.
ES546971A 1984-09-14 1985-09-13 Procedimiento para preparar derivados de bencilftalazinona sustituidos Expired ES8605510A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3433776 1984-09-14

Publications (2)

Publication Number Publication Date
ES546971A0 ES546971A0 (es) 1986-03-16
ES8605510A1 true ES8605510A1 (es) 1986-03-16

Family

ID=6245402

Family Applications (2)

Application Number Title Priority Date Filing Date
ES546971A Expired ES8605510A1 (es) 1984-09-14 1985-09-13 Procedimiento para preparar derivados de bencilftalazinona sustituidos
ES546959A Expired ES8605509A1 (es) 1984-09-14 1985-09-13 Procedimiento para preparar derivados de bencilftalazinona sustituidos

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES546959A Expired ES8605509A1 (es) 1984-09-14 1985-09-13 Procedimiento para preparar derivados de bencilftalazinona sustituidos

Country Status (16)

Country Link
US (1) US4704387A (es)
EP (1) EP0174464B1 (es)
JP (1) JPH0699425B2 (es)
AT (1) ATE49205T1 (es)
CA (1) CA1263652A (es)
DD (1) DD240205A5 (es)
DE (1) DE3575135D1 (es)
DK (1) DK167118B1 (es)
ES (2) ES8605510A1 (es)
GR (1) GR852219B (es)
HU (1) HU197740B (es)
IE (1) IE64839B1 (es)
IL (1) IL75989A0 (es)
MX (1) MX159034A (es)
PT (1) PT81122B (es)
ZA (1) ZA856524B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3677322D1 (de) * 1985-11-11 1991-03-07 Asta Pharma Ag 4-benzyl-1-(2h)-phthalazinon-derivate.
EP0289939A1 (de) * 1987-05-08 1988-11-09 ASTA Pharma AG Neue 4-Benzyl-1-(2H)-phthalazinon-Derivate mit einem Aminosäurerest
ES2053678T3 (es) * 1987-11-13 1994-08-01 Asta Medica Ag Procedimiento para preparar un medicamento con contenido de azelastina para la aplicacion nasal y/u ocular.
US5232919A (en) * 1987-11-13 1993-08-03 Asta Pharma Aktiengesellschaft Azelastine embonate and compositions which contain it
US5271946A (en) * 1988-04-20 1993-12-21 Asta Pharma Aktiengesellschaft Controlled release azelastine-containing pharmaceutical compositions
MC2025A1 (fr) * 1988-04-20 1990-04-25 Asta Pharma Ag Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee
ATE107643T1 (de) * 1989-05-05 1994-07-15 Asta Medica Ag Salze des azelastins mit verbesserter löslichkeit.
JPH04198180A (ja) * 1990-11-28 1992-07-17 Eezai Kagaku Kk ベンジルフタラゾン誘導体の製造方法
DE4207234A1 (de) * 1992-03-07 1993-09-09 Asta Medica Ag Neue aminocarbonsaeure-derivate mit antiallergischer/antiasthmatischer wirkung und verfahren zu deren herstellung
PL2522365T3 (pl) 2004-11-24 2017-05-31 Meda Pharmaceuticals Inc. Kompozycje zawierające azelastynę i sposoby ich zastosowania
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
EA200801996A1 (ru) * 2006-04-20 2009-04-28 Глаксо Груп Лимитед 2-замещенные производные 4-бензилфталазинонов в качестве гистаминовых h1- и h3-антагонистов
ES2369320T3 (es) * 2007-10-11 2011-11-29 Glaxo Group Limited Compuestos de ftalazina y pirido(3,4-d)piridazina como antagonistas del receptor h1.
EP3061501A1 (en) 2015-02-27 2016-08-31 Rottapharm Ltd. Composition for the treatment of acne
EP3117825A1 (en) 2015-07-16 2017-01-18 Rottapharm S.p.A. Oral formulation comprising berberine and morus alba extract

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1293565A (en) * 1969-05-03 1972-10-18 Aspro Nicholas Ltd Aminophthalazines and pharmaceutical compositions thereof
CH572914A5 (es) * 1971-01-22 1976-02-27 Asta Werke Ag Chem Fab
DE2114884A1 (de) * 1971-03-27 1972-10-12 Cassella Farbwerke Mainkur Ag, 6000 Frankfurt Basisch substituierte Derivate des 1(2H)-Phthalazinons
US3813384A (en) * 1972-01-17 1974-05-28 Asta Werke Ag Chem Fab Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof
US4665181A (en) * 1984-05-17 1987-05-12 Pennwalt Corporation Anti-inflammatory phthalazinones

Also Published As

Publication number Publication date
CA1263652A (en) 1989-12-05
IL75989A0 (en) 1985-12-31
ATE49205T1 (de) 1990-01-15
DK167118B1 (da) 1993-08-30
JPS6172782A (ja) 1986-04-14
EP0174464B1 (de) 1990-01-03
PT81122B (pt) 1988-01-22
HUT38340A (en) 1986-05-28
JPH0699425B2 (ja) 1994-12-07
ES546959A0 (es) 1986-03-16
EP0174464A2 (de) 1986-03-19
IE64839B1 (en) 1995-09-06
DK416585A (da) 1986-03-15
DD240205A5 (de) 1986-10-22
GR852219B (es) 1986-01-14
ES546971A0 (es) 1986-03-16
DE3575135D1 (de) 1990-02-08
MX159034A (es) 1989-04-13
ZA856524B (en) 1986-04-30
EP0174464A3 (en) 1986-12-30
ES8605509A1 (es) 1986-03-16
PT81122A (de) 1985-10-01
DK416585D0 (da) 1985-09-13
US4704387A (en) 1987-11-03
HU197740B (en) 1989-05-29
IE852270L (en) 1986-03-14

Similar Documents

Publication Publication Date Title
ES8605510A1 (es) Procedimiento para preparar derivados de bencilftalazinona sustituidos
IE850153L (en) Pyrazole derivatives
ES8607252A1 (es) Procedimiento para preparar derivados de imidazol
ES2000368A6 (es) Un procedimiento para preparar di-t-butilfenoles sustituidos
ES8703438A1 (es) Un procedimiento para la preparacion de derivados de tia (axa) diazol.
ES2001794A6 (es) Un procedimiento para la preparacion de derivados de quinolina
AU558433B2 (en) A fungicidal indanylbenzamide
IE780198L (en) Oxadiazolopyrimidine derivatives
IE831145L (en) Pyridine derivatives
ES8303412A1 (es) Procedimiento de obtencion de nuevas xantinas con actividad farmacologica
IN164615B (es)
ES8207541A1 (es) Procedimiento para la preparacion de derivados de pirimidina
AU587784B2 (en) Phenylbenzoylureas
AU557764B2 (en) 3-formyl-2-nitromethylene-tetrahydro-2h-1,3-thiazine
ES8602021A1 (es) Procedimiento de preparar compuestos espirociclicos antihi- pertensivos
ES2072288T3 (es) Preparacion de enantiomeros de dropropizina.
ES8506421A1 (es) Procedimiento para preparar esteres de acido 2-bromo-4-metilimidazol-5-carboxilico con propiedades herbicidas
SU1121940A1 (ru) Этиловый эфир [3-метил-5- 2′ -оксифенил)-1,2,4-триазолил-1] уксусной кислоты, обладающий психостимулирующим действием
SU1112747A1 (ru) 2-диаллиламино-6-фенил-1,3-оксазин-4-он, проявляющий анальгетическую активность
SU1132513A1 (ru) 2-метиламино-4-оксо-3,6,6-триметил-5,6-дигидро-8н-пирано[4′,3′ : 4,5]тиено[2,3-d]пиримидин или его соли, обладающие противосудорожной активностью
SU1124558A1 (ru) 1-фенил-5- (2′- оксифенил)-3-стирил-1,2,4-триазолы, обладающие транквилизирующим действием
SU1088317A1 (ru) 2-фенилметиламино-6-фенил-1,3-оксазин-4-он, проявляющий транквилизирующую активность

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010301